Center Book Partners LP Roivant Sciences Ltd. Transaction History
Center Book Partners LP
- $1.83 Billion
- Q3 2025
A detailed history of Center Book Partners LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Center Book Partners LP holds 247,443 shares of ROIV stock, worth $5.02 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
247,443
Previous 99,990
147.47%
Holding current value
$5.02 Million
Previous $1.13 Million
232.42%
% of portfolio
0.2%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
376Shares Held
443MCall Options Held
6.03MPut Options Held
2.52M-
Morgan Stanley New York, NY44.3MShares$899 Million0.04% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X040.3MShares$818 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$787 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$718 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$596 Million36.4% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...